H.R. 3, or the Lower Drug Costs Now Act, passed the House last week. It’s very unlikely the Senate or Trump Administration will support the legislation. Last month, Senator McConnell declared the bill “dead on arrival” were it to pass the House and reach the Senate.
So, now our attention turns to a bill with a much more realistic chance of becoming law: S. 2543, or the Prescription Drug Pricing Reduction Act (PDPRA).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,